To that end, the NYSE is proposing to adopt Section 102.09, which sets forth new listing standards applicable to NACs, a new type of public company. This is how the NYSE envisions NACs: ...

Basically, there’s a lot of work involved for the NYSE if a company falls out of compliance: under Sections 802.02 and .03, if a company falls out of compliance with a listing standard, the NYSE ...

HENDERSON, NV / ACCESSWIRE / April 3, 2019 / Not all stocks can be listed with the NYSE. Listing requirements are a set of conditions which a firm must meet before listing a security on one of the ...

Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it received writte ...

Listing requirements comprise the various criteria and minimum standards established by stock exchanges, such as the New York Stock Exchange (NYSE), that companies must meet to list their shares ...

In the Acceptance Letter, the NYSE granted the Company an 18-month period from the Company’s receipt of the NYSE’s Notice of Noncompliance dated March 26, 2025 (the "Plan Period") to regain ...

The New York Stock Exchange has eased its listing requirements until the end of June to take the strain off companies that may have fallen out of compliance due to the market rout spurred by the ...

GrafTech's stock performance has improved, though, and on Friday, Nov. 1, the company received notice from the NYSE that as of Thursday, Oct. 31, the stock had closed above $1 per share for 30 ...

Markforged Receives Continued Listing Standards Notice from the NYSE. November 20, 2023 04:30 PM Eastern Standard Time. WALTHAM, Mass.-- ...

MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for ...

MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for ...